NCT00988624
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Basal Ganglia Diseases, +16 more
- Locations
-
- Pfizer Investigational Site New Haven, Connecticut, United States
Clinical trial condition
Explore clinical trials studying Movement Disorders. Study availability and eligibility vary by location and protocol.
NCT00988624
NCT00807703
NCT00043849
NCT00190008
NCT00931073
NCT00625300
NCT00858546
NCT00750945
NCT00129181